A positive correlation has been found between increased CXCL10 expression and improved prognosis in various human cancers, including CRC, esophageal squamous cell carcinoma, hepatocellular carcinoma and breast cancer [16, 45, 46, 47]. This evidence concerns the gene CXCL10 and colorectal carcinoma.